FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4391711000001104: Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1743661000001111 Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1743671000001118 Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Is a Imipenem 500mg / Cilastatin 500mg powder for solution for injection vials 1 vial true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Is pack of Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has active ingredient Cilastatin sodium false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has active ingredient Imipenem monohydrate false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has AMP Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has specific active ingredient Cilastatin sodium false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has specific active ingredient Imipenem monohydrate false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has specific active ingredient Imipenem monohydrate true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has specific active ingredient Cilastatin sodium true Inferred relationship Existential restriction modifier
Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start